Literature DB >> 29848628

Fatty acid chemical mediator provides insights into the pathology and treatment of Parkinson's disease.

Cesar V Borlongan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29848628      PMCID： PMC6016787          DOI： 10.1073/pnas.1807276115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

Review 1.  Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells.

Authors:  Paolina Pantcheva; Stephanny Reyes; Jaclyn Hoover; Sussannah Kaelber; Cesar V Borlongan
Journal:  Expert Rev Neurother       Date:  2015-09-22       Impact factor: 4.618

2.  Cell Therapy in Parkinson's Disease: Host Brain Repair Machinery Gets a Boost From Stem Cell Grafts.

Authors:  Eleonora Napoli; Cesar V Borlongan
Journal:  Stem Cells       Date:  2017-06       Impact factor: 6.277

3.  Cytosolic and microsomal epoxide hydrolases: differential properties in mammalian liver.

Authors:  K Ota; B D Hammock
Journal:  Science       Date:  1980-03-28       Impact factor: 47.728

4.  Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers.

Authors:  Sumanta Kumar Goswami; Debin Wan; Jun Yang; Carlos A Trindade da Silva; Christophe Morisseau; Sean D Kodani; Guang-Yu Yang; Bora Inceoglu; Bruce D Hammock
Journal:  J Pharmacol Exp Ther       Date:  2016-03-17       Impact factor: 4.030

5.  Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.

Authors:  Qian Ren; Min Ma; Jun Yang; Risa Nonaka; Akihiro Yamaguchi; Kei-Ichi Ishikawa; Kenta Kobayashi; Shigeo Murayama; Sung Hee Hwang; Shinji Saiki; Wado Akamatsu; Nobutaka Hattori; Bruce D Hammock; Kenji Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

6.  Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury.

Authors:  Kenneth I Strauss; Artiom Gruzdev; Darryl C Zeldin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-08-16       Impact factor: 3.072

7.  Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma.

Authors:  Emiko Ono; Stefanie Dutile; Shamsah Kazani; Michael E Wechsler; Jun Yang; Bruce D Hammock; David Nobuhiro Douda; Yacine Tabet; Rayan Khaddaj-Mallat; Marco Sirois; Chantal Sirois; Edmond Rizcallah; Eric Rousseau; Richard Martin; E Rand Sutherland; Mario Castro; Nizar N Jarjour; Elliot Israel; Bruce D Levy
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

8.  Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus.

Authors:  Michael J Devine; Mina Ryten; Petr Vodicka; Alison J Thomson; Tom Burdon; Henry Houlden; Fatima Cavaleri; Masumi Nagano; Nicola J Drummond; Jan-Willem Taanman; Anthony H Schapira; Katrina Gwinn; John Hardy; Patrick A Lewis; Tilo Kunath
Journal:  Nat Commun       Date:  2011-08-23       Impact factor: 14.919

9.  Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers.

Authors:  Lucy Yang; Joseph Cheriyan; David D Gutterman; Ruth J Mayer; Zsuzsanna Ament; Jules L Griffin; Aili L Lazaar; David E Newby; Ruth Tal-Singer; Ian B Wilkinson
Journal:  Chest       Date:  2016-11-21       Impact factor: 9.410

10.  Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.

Authors:  Chao Peng; Ronald J Gathagan; Dustin J Covell; Coraima Medellin; Anna Stieber; John L Robinson; Bin Zhang; Rose M Pitkin; Modupe F Olufemi; Kelvin C Luk; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nature       Date:  2018-05-09       Impact factor: 49.962
View more
  9 in total

Review 1.  Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders.

Authors:  Sydney Zarriello; Julian P Tuazon; Sydney Corey; Samantha Schimmel; Mira Rajani; Anna Gorsky; Diego Incontri; Bruce D Hammock; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2018-11-14       Impact factor: 11.685

2.  Development of Improved Double-Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in Peripheral Blood Mononuclear Cells of Diabetic Patients and the Prefrontal Cortex of Multiple Sclerosis Patients.

Authors:  Dongyang Li; Christophe Morisseau; Cindy B McReynolds; Thomas Duflot; Jérémy Bellien; Rashed M Nagra; Ameer Y Taha; Bruce D Hammock
Journal:  Anal Chem       Date:  2020-04-27       Impact factor: 6.986

Review 3.  Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric Disorders.

Authors:  Jiajing Shan; Kenji Hashimoto
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

4.  May the force be with you: Transfer of healthy mitochondria from stem cells to stroke cells.

Authors:  Cesar V Borlongan; Hung Nguyen; Trenton Lippert; Eleonora Russo; Julian Tuazon; Kaya Xu; Jea-Young Lee; Paul R Sanberg; Yuji Kaneko; Eleonora Napoli
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-30       Impact factor: 6.200

5.  Development of a Highly Sensitive Enzyme-Linked Immunosorbent Assay for Mouse Soluble Epoxide Hydrolase Detection by Combining a Polyclonal Capture Antibody with a Nanobody Tracer.

Authors:  Dongyang Li; Yongliang Cui; Christophe Morisseau; Karen M Wagner; Young Sik Cho; Bruce D Hammock
Journal:  Anal Chem       Date:  2020-08-17       Impact factor: 6.986

6.  A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson's Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity.

Authors:  Jea-Young Lee; Julian P Tuazon; Sydney Corey; Brooke Bonsack; Sandra Acosta; Jared Ehrhart; Paul R Sanberg; Cesario V Borlongan
Journal:  Stem Cell Rev Rep       Date:  2019-10       Impact factor: 6.692

7.  Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model.

Authors:  Jea-Young Lee; Julian P Tuazon; Jared Ehrhart; Paul R Sanberg; Cesario V Borlongan
Journal:  J Cell Mol Med       Date:  2019-05-31       Impact factor: 5.310

Review 8.  Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy.

Authors:  Mercè Pallàs; Santiago Vázquez; Coral Sanfeliu; Carles Galdeano; Christian Griñán-Ferré
Journal:  Biomolecules       Date:  2020-05-01

Review 9.  Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration.

Authors:  Morteza Sarparast; Devon Dattmore; Jamie Alan; Kin Sing Stephen Lee
Journal:  Nutrients       Date:  2020-11-16       Impact factor: 5.717
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.